HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,725-2,736 of 4,505
Drug study icon
CompletedNCT01668797

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 18–65
Countries
United States, Colombia, Malaysia, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01488929

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of TC-5619 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–65
Countries
United States, Hungary, Romania, + 3 others
Sponsor
Targacept Inc.
Drug study icon
CompletedNCT01516424

Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

What is this study about?

Researchers compared Blonanserin and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
SchizophreniaMedication studyAges 18–64
Countries
China
Sponsor
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Behavioral study icon
TerminatedNCT01817387

Enhancing Motivation in Recent Onset Schizophrenia

Official study title

Developing an Intervention Strategy to Enhance Motivation in Recent Onset Schizophrenia

This study ended early.

In San Francisco
SchizophreniaBehavioural studyAges 14–30
Countries
United States
Sponsor
University of California, San Francisco
Other study type icon
CompletedNCT01776112

Enhancing Synaptic Plasticity and Cognition in Schizophrenia

Official study title

Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial

This study has finished and is no longer accepting participants.

In Göttingen
SchizophreniaPlacebo comparisonAges 18–55
Countries
Germany
Sponsor
University Medical Center Goettingen
Drug study icon
CompletedNCT02146547

European Long-acting Antipsychotics in Schizophrenia study

Official study title

European Long-acting Antipsychotics in Schizophrenia Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Innsbruck
SchizophreniaMedication studyAges 18+
Countries
United Kingdom, Belgium, Austria, + 13 others
Sponsor
UMC Utrecht

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.